Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 4
1996 2
1997 1
1998 8
1999 4
2000 2
2001 3
2002 1
2003 2
2004 3
2005 1
2006 2
2007 2
2008 4
2009 2
2010 1
2011 1
2012 2
2014 2
2015 1
2016 3
2017 3
2018 1
2019 3
2020 5
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines.
Dullens B, de Putter R, Lambertini M, Toss A, Han S, Van Nieuwenhuysen E, Van Gorp T, Vanderstichele A, Van Ongeval C, Keupers M, Prevos R, Celis V, Dekervel J, Everaerts W, Wildiers H, Nevelsteen I, Neven P, Timmerman D, Smeets A, Denayer E, Van Buggenhout G, Legius E, Punie K. Dullens B, et al. Among authors: van buggenhout g. J Oncol. 2020 Jun 20;2020:9873954. doi: 10.1155/2020/9873954. eCollection 2020. J Oncol. 2020. PMID: 32655641 Free PMC article. Review.
Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing.
Brison N, Neofytou M, Dehaspe L, Bayindir B, Van Den Bogaert K, Dardour L, Peeters H, Van Esch H, Van Buggenhout G, Vogels A, de Ravel T, Legius E, Devriendt K, Vermeesch JR. Brison N, et al. Among authors: van buggenhout g. Prenat Diagn. 2018 Mar;38(4):258-266. doi: 10.1002/pd.5223. Epub 2018 Feb 19. Prenat Diagn. 2018. PMID: 29388226
The clinical relevance of intragenic NRXN1 deletions.
Cosemans N, Vandenhove L, Vogels A, Devriendt K, Van Esch H, Van Buggenhout G, OliviƩ H, de Ravel T, Ortibus E, Legius E, Aerssens P, Breckpot J, R Vermeesch J, Shen S, Fitzgerald J, Gallagher L, Peeters H. Cosemans N, et al. Among authors: van buggenhout g. J Med Genet. 2020 May;57(5):347-355. doi: 10.1136/jmedgenet-2019-106448. Epub 2020 Jan 13. J Med Genet. 2020. PMID: 31932357
Mesiodens.
Van Buggenhout G, Bailleul-Forestier I. Van Buggenhout G, et al. Eur J Med Genet. 2008 Mar-Apr;51(2):178-81. doi: 10.1016/j.ejmg.2007.12.006. Epub 2008 Jan 4. Eur J Med Genet. 2008. PMID: 18262485 Review.
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant.
Hannes FD, Sharp AJ, Mefford HC, de Ravel T, Ruivenkamp CA, Breuning MH, Fryns JP, Devriendt K, Van Buggenhout G, Vogels A, Stewart H, Hennekam RC, Cooper GM, Regan R, Knight SJ, Eichler EE, Vermeesch JR. Hannes FD, et al. Among authors: van buggenhout g. J Med Genet. 2009 Apr;46(4):223-32. doi: 10.1136/jmg.2007.055202. Epub 2008 Jun 11. J Med Genet. 2009. PMID: 18550696 Free PMC article.
Risk-reducing mastectomy in BRCA carriers: survival is not the issue.
Neven P, Punie K, Wildiers H, Willers N, Van Ongeval C, Van Buggenhout G, Legius E. Neven P, et al. Among authors: van buggenhout g. Breast Cancer Res Treat. 2020 Jan;179(1):251-252. doi: 10.1007/s10549-019-05440-4. Epub 2019 Sep 20. Breast Cancer Res Treat. 2020. PMID: 31541380 No abstract available.
Angelman syndrome (AS, MIM 105830).
Van Buggenhout G, Fryns JP. Van Buggenhout G, et al. Eur J Hum Genet. 2009 Nov;17(11):1367-73. doi: 10.1038/ejhg.2009.67. Epub 2009 May 20. Eur J Hum Genet. 2009. PMID: 19455185 Free PMC article. Review.
60 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page